| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Hilzinger Kurt J is a Director at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 20 buys and 0 sells.
Estimated insider holdings value: $669K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 400,000 | $0.44 | $176,520.00 | +1,691% | - | - | |
| Oct 5, 2022 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 111,203 | $1.28 | $142,512.15 | +13.6% | -16.0% | -81.7% | |
| Oct 3, 2022 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 88,797 | $1.24 | $110,500.24 | +10.1% | -15.3% | -80.8% | |
| Mar 1, 2022 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 27,708 | $1.69 | $46,826.52 | +11.3% | -31.5% | -35.7% | |
| Feb 28, 2022 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 47,160 | $1.48 | $69,693.60 | +10.8% | -29.4% | -33.1% | |
| Feb 23, 2022 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 175,132 | $1.47 | $256,969.93 | +123.5% | +6.4% | -17.4% | |
| Feb 4, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 5,983 | $0.80 | $4,786.40 | +3.3% | - | - | |
| Feb 1, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 19,390 | $0.75 | $14,559.80 | +3.9% | - | - | |
| Jan 29, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 32,112 | $0.71 | $22,690.96 | +7.6% | - | - | |
| Jan 23, 2019 | OTLK Outlook Therapeutics, Inc. | Director | Buy | 13,015 | $0.68 | $8,827.54 | +5.4% | - | - |